share

3-Methyl-2-[2'-(Methylsulfonyl)Biphenyl-4-Yl]-5-(Trifluoromethyl)Quinoxaline CAS NO 1221265-39-9


Unit Price:

CAS No.:1221265-39-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

3-Methyl-2-[2'-(Methylsulfonyl)Biphenyl-4-Yl]-5-(Trifluoromethyl)Quinoxaline CAS NO 1221265-39-9 is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value in modern organic synthesis, particularly for the development of novel active pharmaceutical ingredients (APIs) with targeted therapeutic effects. It is primarily sought by research institutions and manufacturers in the pharmaceutical and agrochemical sectors engaged in the discovery and production of new chemical entities.

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
  • Agrochemical Research: Used in the development of new-generation pesticides and herbicides, leveraging its trifluoromethyl and quinoxaline motifs for enhanced bioactivity.
  • Material Science: Serves as a precursor for functional organic materials, including organic light-emitting diodes (OLEDs) and electronic chemicals.
  • Chemical Synthesis: Employed in advanced organic reactions, such as cross-coupling and cyclization, to create complex molecular architectures.
  • Life Science Research: Utilized as a biochemical tool or reference standard in pharmacological and biological studies.

Basic Information

Product Name 3-Methyl-2-[2'-(Methylsulfonyl)Biphenyl-4-Yl]-5-(Trifluoromethyl)Quinoxaline
CAS No. 1221265-39-9
Molecular Formula C23H17F3N2O2S
Molecular Weight 442.45 g/mol
Synonyms 3-Methyl-2-[4-(2-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)quinoxaline; 2-(4-(2-(Methylsulfonyl)phenyl)phenyl)-3-methyl-5-(trifluoromethyl)quinoxaline; 1221265-39-9; Biphenyl-4-yl quinoxaline derivative; Methylsulfonyl biphenyl quinoxaline; Trifluoromethyl quinoxaline intermediate
EINECS Contact for details

Quality Control

Our production of 3-Methyl-2-[2'-(Methylsulfonyl)Biphenyl-4-Yl]-5-(Trifluoromethyl)Quinoxaline adheres to stringent quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided and can be tailored to meet specific customer or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from heat sources and incompatible materials. The container should be kept tightly sealed to protect from moisture.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (HPLC) Conforms
Identification (IR) Conforms
Purity (HPLC) ≥ 98.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 20 ppm
Single Unknown Impurity (HPLC) ≤ 0.5%
Total Impurities (HPLC) ≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.